Indonesia ENT Devices Market Report 2022 to 2030

Indonesia ENT Devices Market Analysis

$ 3999

Indonesia's ENT Devices Market is projected to grow from $140 Mn in 2022 to $220 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Indonesia ENT devices market include Innonovatech Medica, Dharma Intisemesta, and Bina Medika Lestari.

ID: IN10IDMD009 CATEGORY: Medical Devices GEOGRAPHY: Indonesia AUTHOR: Dr. Vishwa Modhia

Buy Now

Indonesia ENT Devices Market Analysis Summary

Indonesia's ENT Devices Market is projected to grow from $140 Mn in 2022 to $220 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30.

Indonesia is a lower middle-income, developing country located in Southeastern Asia between the Indonesian Ocean and the Pacific Ocean. Healthcare is a national priority in Indonesia, and the central and provincial governments are continuing to create and modernize healthcare facilities. Indonesia now has 2,925 hospitals, with around 63% privately run. According to the Indonesian Statistic Bureau, there will be 10,205 public Health Community Centers (PUSKESMAS) in operation by 2020, providing comprehensive primary healthcare and immunizations. Indonesia's government spent 3.4% of its GDP on healthcare in 2020.

Indonesia ENT Devices Market

Market Dynamics

Market Growth Drivers Analysis

There is an increasing demand in Indonesia for more modern and creative ENT devices. As the older population consumes more ENT gadgets, the need will rise. In 2020, 21 Mn Indonesians would have reached the age of 65. By 2025, the aged would account for 12.5 % of the Indonesian population, a 45 % increase from 2015. (8.6 %). Increased public awareness of the importance of healthcare, the expansion of public and private hospitals, and the implementation of Indonesia's public health insurance system known as "BPJS-Kesehatan" (Jaminan Kesehatan Nasional, or JKN) in 2014 have all resulted in a greater demand for more sophisticated and modern medical devices. These aspects could boost Indonesia's ENT Devices Market.

Market restrains.

Over 90% of the country's medical equipment and supplies are imported. Despite the fact that the Indonesian government has imposed local content criteria and import levies, the country continues to rely on imported innovative medical technology. In addition to the regular 10% value-added tax, medical equipment is subject to a 5% - 30% import tax, depending on the kind. These factors may deter new entrants into the Indonesia ENT Devices Market.

Competitive Landscape

Key Players

Bina Medika Lestari: This company produces a range of medical devices, including ENT instruments such as ear specula, nasal specula, and laryngeal mirrors
Dharma Intisemesta: This company produces medical equipment and supplies, including ENT devices such as endoscopes, laryngoscopes, and otoscopes
MEDION: This company produces a variety of medical devices and supplies, including ENT instruments such as forceps, scissors, and retractors
Innonovatech Medica: This company produces medical equipment and supplies, including ENT devices such as nasal cannulas, oxygen masks, and suction catheters
Fajar Mas Murni: This company produces medical devices, including ENT instruments such as nasal forceps, ear forceps, and tongue depressors

Recent Notable Updates

February 2022: The Ministry of Health of Indonesia has created a sectoral e-Katalog for medical equipment. Previously, LKPP managed e-Katalog, also known as the national e-Katalog, for all products procured by government institutions, from street lighting to pacemakers. The LKPP e-Katalog is currently divided into a national e-Katalog for products necessary across the country and sectoral e-Katalogs for ministries such as the Ministry of Health. This means that medical devices, health-supporting instruments, and domestic health goods will no longer be assessed by LKPP and will instead be reviewed by Indonesia's Ministry of Health.

Healthcare Policies and Reimbursement Scenarios

In Indonesia, the regulatory framework for medical devices, including ENT devices, is overseen by the National Agency of Drug and Food Control (NA-DFC) through its Medical Device Supervision Directorate. To be sold in Indonesia, medical devices must be registered with the NA-DFC and comply with the country's regulatory requirements, including safety and quality standards. The Indonesian government provides healthcare coverage through the national health insurance program, known as the Jaminan Kesehatan Nasional (JKN).

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

ENT Device Market Segmentation

The ENT Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Diagnostic Devices
Surgical Devices
Hearing Aids
Hearing Implants
Co2 Lasers
Image-Guided Surgery Systems

By Diagnostic Devices (Revenue, USD Billion):

Endocsopes
Hearing Screening Devices

By Surgical Device (Revenue, USD Billion):

Powered Surgical Instruments
Radiofrequency (RF) Handpieces
Handheld Instruments
Balloon Sinus Dilation Devices
ENT Supplies
Ear Tubes
Voice Prosthesis Devices

By End Users (Revenue, USD Billion):

Hospitals and Ambulatory Settings
Home Use
ENT Clinics

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.